BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Pharmalink AB 

Karlavägen 18

Stockholm    SE-102 49  Sweden
Phone: 46-0-8-505-66-312 Fax: 46-0-8-611-3303


SEARCH JOBS




Industry
Pharmaceutical






 Company News
Data From Clinical Study Of Pharmalink AB’s Nefecon® To Be Presented At American Society Of Nephrology’s Kidney Week 2014 11/3/2014 12:57:44 PM
Data From Clinical Study Of Pharmalink AB's Nefecon® To Be Presented At American Society Of Nephrology's Kidney Week 2014 11/3/2014 7:25:58 AM
Pharmalink AB Extends Patent Protection For Nefecon® Treatment For Renal Disease 10/27/2014 7:46:30 AM
Pharmalink AB Elects Bengt Julander As Chairman 10/14/2014 8:32:40 AM
Pharmalink AB's Core Patents For Nefecon® Treatment For Renal Disease Granted In United States, Europe, China And Hong Kong 7/10/2014 9:49:12 AM
Pharmalink AB Strengthens its Board Of Directors 7/7/2014 10:58:08 AM
Pharmalink AB Receives US Orphan Drug Designation for Busulipo™, its Novel Oncology Product for Bone Marrow Transplantation 10/29/2013 10:24:04 AM
Pharmalink AB Snags $15 Million to Undertake Pivotal Studies With Lead Programs in Cancer Therapy and Renal Disease 10/4/2013 6:54:58 AM
Pharmalink AB Raises SEK 35 Million Through Share Issue 1/4/2012 10:05:08 AM
Pharmalink AB Gains Exclusive Licence to Archimedes Pharma's TARGIT(R) Technology for Nefecon(R) (PL-56) Program 12/13/2011 10:13:24 AM
12